Analysts at Guggenheim boosted the price target and estimates through 2014 for pharmacy retailer CVS Caremark Corporation (CVS) on Thursday after the company increased its own guidance.
The analysts maintain a “Buy” rating on CVS and now see shares reaching $60. This new target suggests a 17% upside to Wednesday’s closing price of $51.24.
CVS shares were down slightly during morning trading on Thursday. The stock is up about +19% over the past year.
The Bottom Line
Shares of CVS Caremark (CVS) have a dividend yield of 1.76% based on Thursday’s intraday trading price of $51.12 and the company’s annualized dividend payout of 90 cents per share.
CVS Caremark Corporation (CVS) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.